SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Total Assets | ₹416 Cr | ₹407 Cr | ₹378 Cr | ₹308 Cr | ₹184 Cr |
What is the latest Total Assets ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Total Assets |
|---|---|
| Mar2025 | ₹416 Cr |
| Mar2024 | ₹407 Cr |
| Mar2023 | ₹378 Cr |
| Mar2022 | ₹308 Cr |
| Mar2017 | ₹184 Cr |
How is Total Assets of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Total Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹416 Cr | 2.18 | |
| Mar2024 | ₹407 Cr | 7.69 | |
| Mar2023 | ₹378 Cr | 22.58 | |
| Mar2022 | ₹308 Cr | 67.59 | |
| Mar2017 | ₹184 Cr | - | |
Compare Total Assets of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,234.2 Cr | -4% | -5.8% | -28.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,842.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,860.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹192,687.0 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| CIPLA | ₹112,593.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,364.9 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -4% |
-5.8% |
-28.3% |
| SENSEX | -1% |
-0.9% |
-7.5% |
You may also like the below Video Courses